These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Frequency of hyperuricemia and effect of calcineurin inhibitors on serum uric acid levels in liver transplanted children. Tumgor G; Arikan C; Kilic M; Aydogdu S Pediatr Transplant; 2006 Sep; 10(6):665-8. PubMed ID: 16911488 [TBL] [Abstract][Full Text] [Related]
3. [Diagnosis and prevention of uric acid stones]. Ferrari P; Bonny O Ther Umsch; 2004 Sep; 61(9):571-4. PubMed ID: 15493118 [TBL] [Abstract][Full Text] [Related]
4. Who makes uric acid stones and why--observations from a renal stones clinic. Stansbridge EM; Griffin DG; Walker V J Clin Pathol; 2013 May; 66(5):426-31. PubMed ID: 23454727 [TBL] [Abstract][Full Text] [Related]
6. [Pathophysiology, diagnosis and conservative therapy of non-calcium kidney calculi]. Hochreiter W; Knoll T; Hess B Ther Umsch; 2003 Feb; 60(2):89-97. PubMed ID: 12649987 [TBL] [Abstract][Full Text] [Related]
7. [Xanthinuria with xanthine lithiasis in a patient with Lesch-Nyhan syndrome under allopurinol therapy]. Rebentisch G; Stolz S; Muche J Aktuelle Urol; 2004 Jun; 35(3):215-21. PubMed ID: 15258855 [TBL] [Abstract][Full Text] [Related]
8. [Urate nephrolithiasis. Cause of consequence?]. Mertz DP Fortschr Med; 1976 Jul; 94(20-21):1160-4. PubMed ID: 955552 [TBL] [Abstract][Full Text] [Related]
9. Uric acid nephrolithiasis: current concepts and controversies. Shekarriz B; Stoller ML J Urol; 2002 Oct; 168(4 Pt 1):1307-14. PubMed ID: 12352383 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of factors involved in calcium stone formation. Abraham PA; Smith CL Miner Electrolyte Metab; 1987; 13(3):201-8. PubMed ID: 3627051 [TBL] [Abstract][Full Text] [Related]
11. [Two cases of uric acid stones unsuccessfully dissociated by oral chemolysis]. Funahashi M; Yamada T; Murayama T Hinyokika Kiyo; 2006 Jan; 52(1):47-8. PubMed ID: 16479990 [TBL] [Abstract][Full Text] [Related]
12. Urinary alkalization for the treatment of uric acid nephrolithiasis. Cicerello E; Merlo F; Maccatrozzo L Arch Ital Urol Androl; 2010 Sep; 82(3):145-8. PubMed ID: 21121431 [TBL] [Abstract][Full Text] [Related]
13. Dissolution of radiolucent renal stones by oral alkalinization with potassium citrate/potassium bicarbonate. Trinchieri A; Esposito N; Castelnuovo C Arch Ital Urol Androl; 2009 Sep; 81(3):188-91. PubMed ID: 19911683 [TBL] [Abstract][Full Text] [Related]
15. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy. Pak CY; Sakhaee K; Fuller CJ Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957 [TBL] [Abstract][Full Text] [Related]
16. Hypocitraturia as a pathogenic risk factor in the mixed (calcium oxalate/uric acid) renal stones. Alvarez Arroyo MV; Traba ML; Rapado A Urol Int; 1992; 48(3):342-6. PubMed ID: 1589930 [TBL] [Abstract][Full Text] [Related]
17. The importance of potassium citrate and potassium bicarbonate in the treatment of uric acid renal stones. Barbera M; Tsirgiotis A; Barbera M; Paola Q Arch Ital Urol Androl; 2016 Dec; 88(4):341-342. PubMed ID: 28073209 [TBL] [Abstract][Full Text] [Related]
18. Uric acid elimination in the urine. Pathophysiological implications. Marangella M Contrib Nephrol; 2005; 147():132-148. PubMed ID: 15604613 [TBL] [Abstract][Full Text] [Related]
19. Acetazolamide is an effective adjunct for urinary alkalization in patients with uric acid and cystine stone formation recalcitrant to potassium citrate. Sterrett SP; Penniston KL; Wolf JS; Nakada SY Urology; 2008 Aug; 72(2):278-81. PubMed ID: 18533229 [TBL] [Abstract][Full Text] [Related]